Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MMP12 | P39900 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | HTR2B | P41595 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16502144 | 0.91 | CYP1A2 (0.46) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 | |
| SCHEMBL1905297 | 0.90 | ESR1 (0.46) | MAPTNPC1RAB9APDK2TDP2 | |
| SCHEMBL30395577 | 0.88 | ALDH1A1 (0.63) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 | |
| SCHEMBL3414807 | 0.88 | ALDH1A1 (0.63) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 | |
| SCHEMBL16502132 | 0.88 | CYP1A2 (0.44) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 | |
| SCHEMBL1482804 | 0.86 | MAPT (0.57) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 | |
| SCHEMBL1666630 | 0.86 | MAPT (0.57) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 | |
| SCHEMBL30172496 | 0.86 | MAPT (0.57) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 | |
| SCHEMBL13504436 | 0.85 | TDP2 (0.51) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 | |
| SCHEMBL1480687 | 0.84 | MAPT (0.47) | ALDH1A1MAPTHPGDSMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8299459-B2 | Diindenopicene compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2012-10-30 | — | — | US | disclosed |
| US-20110204349-A1 | DIINDENOPICENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110204349-A1 | DIINDENOPICENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | ALDH1A2, CYP46A1, NR2E3 | ALDH1A1 73/4885MAPT 2186/4885HPGD 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.